CFB
PBH icon

Cullen/Frost Bankers’s Prestige Consumer Healthcare PBH Stock Holding History

Cullen/Frost Bankers’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16
Closed -$1.28K – 1416
2025
Q2 		$1.28K Hold
16
– – ﹤0.01% 1221
2025
Q1 		$1.38K Hold
16
– – ﹤0.01% 1193
2024
Q4 		$1.25K Buy
+16
New +$1.24K ﹤0.01% 1209
2022
Q2 		– Sell
-9
Closed – – 1160
2022
Q1 		$0 Hold
9
– – ﹤0.01% 1232
2021
Q4 		$1K Buy
+9
New +$534 ﹤0.01% 1144

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Cullen/Frost Bankers's PBH Position: Q3 2025 in Review

Cullen/Frost Bankers sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 16 shares — an estimated $1.28K sold.

Cullen/Frost Bankers first reported a position in PBH in Q4 2021 and held it in 5 quarters. The position peaked at $1.38K in Q1 2025. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Cullen/Frost Bankers reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
  • Cullen/Frost Bankers sold 16 Prestige Consumer Healthcare shares in Q3 2025, an estimated $1.28K.
  • Cullen/Frost Bankers first reported a position in Prestige Consumer Healthcare in Q4 2021 and held it in 5 quarters.
  • Cullen/Frost Bankers's Prestige Consumer Healthcare position peaked at $1.38K in Q1 2025.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Cullen/Frost Bankers's 13F filing for Q3 2025, filed 31 Oct 2025.